Currently submitted to: JMIR Preprints
Date Submitted: Nov 9, 2023
Open Peer Review Period: Nov 9, 2023 - Oct 24, 2024
(currently open for review and needs more reviewers - can you help?)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
mHealth platforms for dementia screening or therapy: An updated critical literature review of reviews
ABSTRACT
Background:
Due to the varying symptomology of Alzheimer’s disease (AD), primary care providers (PCPs) find it challenging to disentangle normal cognitive age-related dysfunction versus those individuals on the clinical pathway of AD. Mobile health (mHealth) technology shows great potential in for improving health outcomes because of its mobility, instantaneous access for both the patient and PCP, and ease of use.
Objective:
This critical review aims to summarize findings from other reviews published recently on mHealth platforms used in remote cognitive screening or therapy for AD.
Methods:
Rapid scoping review techniques were still used to synthesize and create a broad understanding of mHealth platforms and it usage in AD screening or therapy. The PubMed data base was searched on November 8, 2023, for relevant reviews using the strategy mobile and cognitive impairment: “((mhealth) OR (mobile health)) AND (subjective cognitive decline OR mild cognitive impairment OR Alzheimer disease)”. Limits were placed in terms of article type (systematic review or review), and language (English).
Results:
The initial search identified 23 unique citations. The titles and abstracts were assessed based on the inclusion criteria, and of the 23 unique citations, 7 (30%) were excluded after title and abstract screening. Of those remaining, 5 (2%) were excluded as they were not relevant to the topic, 2 (9%) did not include mHealth components, 1 (4%) did not include AD-related outcome and 1 (4%) was a narrative review. Hence, of the 16 (70%) reviews included for full-text screening, 7 (30%) were included in the research synthesis.
Conclusions:
mHealth platforms have the potential to increase cognitive screening uptake and allow PCPs to remotely monitor their patients, provide support to caregivers and collect relevant health data. Yet, some important considerations are cognitive test features (i.e., characteristics, duration or frequency, psychometric properties), characteristics of patient (experience, knowledge and support with technology), usability of platform, and delivery method. Future interventions should consider incorporating social media platforms like WhatsApp or Facebook, to offer more customized, educational services to patients and their caregivers. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.